Publication | Open Access

Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine (‘ecstasy’) through iterative chemical redesign: mechanisms and pathways to cell death

Lymphoid NeoplasiaAnti-lymphoma PotentialMedicineDrug DiscoveryAnti-cancer AgentIterative Chemical RedesignPharmacologyCell BiologyTumor BiologyDrug Toxicity